Revelation Biosciences (REVB) Shares Outstanding (Entity) (2020 - 2026)
Revelation Biosciences' Shares Outstanding (Entity) came in at 3.91 million for Q2 2026, compared with 200,668 a year earlier and up 21.8% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
For FY2025, Revelation Biosciences' Shares Outstanding (Entity) was 620,785.
- Shares Outstanding (Entity) carries a five-year compound annual growth rate of 93.7% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 14,292 in FY2024 (+937.2%), 1,378 in FY2023 (-50.9%), 2,807 in FY2022 (-70.4%) and 9,477 in FY2021 (-58.4%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2020.
- The fastest year-over-year change in Shares Outstanding (Entity) over five years came in Q4 2024 (growth of 937.2%), and the weakest in Q1 2023 (a decline of 85.3%).
- Business Quant data shows REVB's Shares Outstanding (Entity) at 3.21 million (Q1 2026), 620,785 (Q4 2025) and 661,183 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - | 3.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.91 Mn |
| Mar 31, 2026 | 3.21 Mn |
| Dec 31, 2025 | 620,785.00 |
| Sep 30, 2025 | 661,183.00 |
| Jun 30, 2025 | 200,668.00 |
| Mar 31, 2025 | 80,316.00 |
| Dec 31, 2024 | 14,292.00 |
| Sep 30, 2024 | 13,958.00 |
| Jun 30, 2024 | 8,559.00 |
| Mar 31, 2024 | 5,676.00 |
| Dec 31, 2023 | 1,378.00 |
| Sep 30, 2023 | 32,798.00 |
| Jun 30, 2023 | 32,798.00 |
| Mar 31, 2023 | 11,514.00 |
| Dec 31, 2022 | 2,807.00 |
| Sep 30, 2022 | 3,557.00 |
| Jun 30, 2022 | 2,299.00 |
| Mar 31, 2022 | 78,555.00 |
| Dec 31, 2021 | 9,477.00 |
| Sep 30, 2021 | 9,477.00 |
API Access
Revelation Biosciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();